These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 22836491)

  • 1. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment models for cancer-associated venous thromboembolism.
    Dutia M; White RH; Wun T
    Cancer; 2012 Jul; 118(14):3468-76. PubMed ID: 22086826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
    Pabinger I; Ay C
    Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
    Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
    Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.
    Uaprasert N; Voorhees PM; Mackman N; Key NS
    Eur J Cancer; 2010 Jul; 46(10):1790-9. PubMed ID: 20385482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin.
    Kato A; Takano H; Ichikawa A; Koshino M; Igarashi A; Hattori K; Nagata K
    Thromb Res; 2013 Feb; 131(2):140-4. PubMed ID: 23232090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboprophylaxis in non-surgical cancer patients.
    Cohen AT; Gurwith MM; Dobromirski M
    Thromb Res; 2012 Apr; 129 Suppl 1():S137-45. PubMed ID: 22682125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of weighted and scored risk assessment models for venous thromboembolism.
    Spyropoulos AC; McGinn T; Khorana AA
    Thromb Haemost; 2012 Dec; 108(6):1072-6. PubMed ID: 23138506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
    Zamagni E; Brioli A; Tacchetti P; Zannetti B; Pantani L; Cavo M
    Semin Thromb Hemost; 2011 Apr; 37(3):209-19. PubMed ID: 21455855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
    Ay C; Pabinger I
    Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
    Aikens GB; Rivey MP; Hansen CJ
    Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
    Anaissie EJ; Coleman EA; Goodwin JA; Kennedy RL; Lockhart KD; Stewart CB; Coon SK; Bailey C; Barlogie B
    Cancer; 2012 Jan; 118(2):549-57. PubMed ID: 21720994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.
    Al-Ani F; Bermejo JM; Mateos MV; Louzada M
    Thromb Res; 2016 May; 141():84-90. PubMed ID: 26986753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer and venous thrombosis: current comprehensions and future perspectives.
    Lauw MN; van Doormaal FF; Middeldorp S; Buller HR
    Semin Thromb Hemost; 2013 Jul; 39(5):507-14. PubMed ID: 23629821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.
    Leleu X; Rodon P; Hulin C; Daley L; Dauriac C; Hacini M; Decaux O; Eisemann JC; Fitoussi O; Lioure B; Voillat L; Slama B; Al Jijakli A; Benramdane R; Chaleteix C; Costello R; Thyss A; Mathiot C; Boyle E; Maloisel F; Stoppa AM; Kolb B; Michallet M; Lamblin A; Natta P; Facon T; Elalamy I; Fermand JP; Moreau P
    Thromb Haemost; 2013 Oct; 110(4):844-51. PubMed ID: 23903204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
    Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
    Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.